{"disease":{"id":"skin-diseases-infectious","name":"skin diseases infectious"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00711802","title":"Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":396,"lead_sponsor_name":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT00761215","title":"Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":192,"lead_sponsor_name":"Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT04485676","title":"Dalbavancin in Real Clinical Practice in Spain","phase":"","overall_status":"COMPLETED","enrollment_count":187,"lead_sponsor_name":"Angelini Farmacéutica","has_results":false},{"nct_id":"NCT00865280","title":"Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":143,"lead_sponsor_name":"Paratek Pharmaceuticals Inc","has_results":true},{"nct_id":"NCT01967225","title":"Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT02276482","title":"Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT03981822","title":"A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Verrica Pharmaceuticals Inc.","has_results":true},{"nct_id":"NCT03487549","title":"Cantharidin and Occlusion in Verruca Epithelium","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Verrica Pharmaceuticals Inc.","has_results":true},{"nct_id":"NCT05608382","title":"Effect of an Antiseptic Solution on the Skin Microbiome","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Center for Innovation and Research Organization","has_results":false},{"nct_id":"NCT03643952","title":"Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}